Baseline characteristics and treatment response predictive of nAMD outcomes with ranibizumab therapy in treatment-naive patients: the RACER subgroup analysis

被引：0
|
作者：
Ching-Yao Tsai
Chien-Liang Wu
Cheng-Kuo Cheng
Yun-Dun Shen
Wen-Chuan Wu
Pei-Chang Wu
Arslan Tsai
Jiann-Torng Chen
机构：
[1] Taipei City Hospital,Institute of Public Health
[2] National Yang Ming Chiao Tung University,Department of Business Administration
[3] Fu Jen Catholic University,undefined
[4] Municipal Wan Fang Hospital,undefined
[5] Shin Kong Wu Ho-Su Memorial Hospital,undefined
[6] Taipei Medical University-Shung Ho Hospital,undefined
[7] Kang-Ning General Hospital,undefined
[8] Kaohsiung Medical University Chung-Ho Memorial Hospital,undefined
[9] Park One International Hospital,undefined
[10] Kaohsiung Chang Gung Memorial Hospital,undefined
[11] Clinical Development and Medical Affairs,undefined
[12] Novartis Taiwan,undefined
[13] Tri-Service General Hospital,undefined
[14] National Defense Medical Center,undefined
来源：
BMC Ophthalmology | / 23卷
关键词：
Anti-VEGF; BCVA; Clinical practice; CRT; nAMD; RACER; Ranibizumab; Real-world; Taiwan; Treatment switch; Treatment response;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] FUSION regimen: ranibizumab in treatment-naive patients with exudative age-related macular degeneration and relatively good baseline visual acuity
    Mones, Jordi
    Biarnes, Marc
    Trindade, Fabio
    Casaroli-Marano, Ricardo
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2012, 250 (12) : 1737 - 1744
  • [22] Outcomes of cancer therapy administered to treatment-naive lung cancer patients in the intensive care unit
    Chen, Yen-Fu
    Lin, Jou-Wei
    Ho, Chao-Chi
    Yang, Ching-Yao
    Chang, Chia-Hao
    Huang, Tao-Min
    Chen, Chung-Yu
    Chen, Kuan-Yu
    Shih, Jin-Yuan
    Yu, Chong-Jen
    [J]. JOURNAL OF CANCER, 2017, 8 (11): : 1995 - 2003
  • [23] Contribution of Obinutuzumab to Acalabrutinib Therapy in Patients with Treatment-Naive Chronic Lymphocytic Leukemia: Analysis of Survival Outcomes By Genomic Features
    Davids, Matthew S.
    Sharman, Jeff P.
    Eyre, Toby A.
    Woyach, Jennifer A.
    de Miranda, Paulo Andre P.
    Shahkarami, Mina
    Butturini, Anna
    Emeribe, Ugochinyere
    Byrd, John C.
    [J]. BLOOD, 2022, 140 : 4173 - 4175
  • [24] Contribution of obinutuzumab to acalabrutinib therapy in patients with treatment-naive chronic lymphocytic leukemia: analysis of survival outcomes by genomic features
    Schabath, R.
    Davids, M. S.
    Sharman, J. P.
    Eyre, T. A.
    Woyach, J. A.
    de Miranda, P. A. P.
    Shahkarami, M.
    Butturini, A.
    Emeribe, U.
    Byrd, J. C.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 218 - 218
  • [25] Eyes With Acute, Treatment-Naive CRVO and Foveal Intraretinal Hemorrhage: Characteristics and Outcomes
    Mir, Tahreem A.
    Thomas, Akshay S.
    Yoon, Stephen P.
    Birnbaum, Faith
    Goerlitz-Jessen, Mark
    Fekrat, Sharon
    [J]. OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2019, 50 (12): : 752 - 759
  • [26] Inclusion of Synovial Tissue-Derived Characteristics in a Nomogram for the Prediction of Treatment Response in Treatment-Naive Rheumatoid Arthritis Patients
    Alivernini, Stefano
    Tolusso, Barbara
    Gessi, Marco
    Gigante, Maria Rita
    Mannocci, Alice
    Petricca, Luca
    Perniola, Simone
    Di Mario, Clara
    Bui, Laura
    Fedele, Anna Laura
    Capacci, Annunziata
    Bruno, Dario
    Peluso, Giusy
    La Torre, Giuseppe
    Federico, Francesco
    Ferraccioli, Gianfranco
    Gremese, Elisa
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 (09) : 1601 - 1613
  • [27] Response to tenofovir treatment of treatment-naive and adefovir experienced patients with chronic hepatitis b
    Keskin, Onur
    Ormeci, Asli Cifcibasi
    Kabacam, Gokhan
    Akyuz, Filiz
    Aniktar, Hatice
    Karaca, Cetin
    Idilman, Ramazan
    Kaymakoglu, Sabahattin
    Yurdaydin, Cihan
    [J]. HEPATOLOGY, 2012, 56 : 394A - 395A
  • [28] Beta cell activity modulates treatment response in treatment-naive patients: exploratory analysis from the VERIFY study
    Matthews, D. R.
    Paldanius, P. M.
    Bader, G.
    Del Prato, S.
    [J]. DIABETOLOGIA, 2021, 64 (SUPPL 1) : 174 - 175
  • [29] ELN Risk Stratification Is Not Predictive of Outcomes for Treatment-Naive Patients with Acute Myeloid Leukemia Treated with Venetoclax and Azacitidine
    Doehner, Hartmut
    Pratz, Keith W.
    DiNardo, Courtney D.
    Jonas, Brian A.
    Pullarkat, Vinod A.
    Thirman, Michael J.
    Recher, Christian
    Schuh, Andre C.
    Babu, Sunil
    Dail, Monique
    Ku, Grace
    Sun, Yan
    Potluri, Jalaja
    Chyla, Brenda
    Pollyea, Daniel A.
    [J]. BLOOD, 2022, 140 : 1441 - 1444
  • [30] Assessment of baseline symptom burden in treatment-naive patients with lung cancer: an observational study
    Mendoza, Tito R.
    Kehl, Kenneth L.
    Bamidele, Oluwatosin
    Williams, Loretta A.
    Shi, Qiuling
    Cleeland, Charles S.
    Simon, George
    [J]. SUPPORTIVE CARE IN CANCER, 2019, 27 (09) : 3439 - 3447
12345